12:00 AM
 | 
Jan 14, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Dotarem gadoterate meglumine regulatory update

FDA's Medical Imaging Drugs Advisory Committee will meet on Feb. 14 to discuss an NDA from Guerbet for Dotarem gadoterate...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >